Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, ...

Q1 2025 Management View CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...

Unity Biotechnology, a Bay Area company that won buzz for its approach to anti-aging research, is laying off all of its workers, including top executives.